The Awaken India Movement (AIM) has launched a nationwide campaign urging Indian citizens to express their strong objections against proposed drug trials that would allow multinational pharmaceutical companies to conduct first-in-human clinical trials on Indian citizens. The central message of the movement is clear: “India is not a laboratory, and Indian citizens are not guinea pigs.”

Recent discussions, as reported by The Economic Times on November 12, 2026, indicate that the Indian government is considering opening the door to foreign pharmaceutical firms for conducting early-phase clinical trials of experimental drugs in India. This raises serious concerns about the safety and rights of individuals who might volunteer for these trials since the effects of these drugs on humans are unknown.
Why This Matters
- Historical Precedents: The movement recalls past controversies, particularly the HPV vaccine trials conducted by PATH (a global health organization) under the Bill & Melinda Gates Foundation. The 72nd Parliamentary Standing Committee Report, published on August 30, 2013, highlighted significant violations, such as lack of informed consent and ethical protection of participants, primarily involving young girls.
- Public Statements: Bill Gates, in a 2024 interview, referred to India as a “kind of laboratory to try things,” which sparked public outrage and highlighted the perception that India may be open to experimentation without proper ethical considerations.
AIM presents several legal objections against the proposed drug trials:
- Article 21 of the Indian Constitution: This article guarantees the right to life and personal liberty. The AIM argues that this right cannot be compromised for commercial interests or experimental drugs.
- Regulatory Compliance: The Drugs and Cosmetics Act (1940) and New Drugs and Clinical Trials Rules (2019) require strict registration and oversight of ethics committees. Any trial that bypasses these regulations is deemed unlawful and could face legal repercussions.
- 72nd Parliamentary Committee Report: The AIM demands that any future trials must align with the committee’s recommendations, ensuring that previous violations do not reoccur.
AIM is calling for immediate action from the government, including:
- Suspension of the Proposal: They want discussions about regulatory changes halted until there is a thorough public consultation and independent ethical review.
- Transparency: Full disclosure of proposed amendments and assurances that these trials will not exploit vulnerable citizens, especially children.
- Public Disclosure: Authorities should reveal how they address prior recommendations about the HPV vaccine controversy.
- Formal Response: AIM requests a documented response from the involved authorities regarding these objections.
Warning of Legal Action
The movement warns that if the government proceeds with safety measures that infringe Article 21 or reduce protections for human subjects, they will take legal action, including seeking intervention from the National Human Rights Commission and filing public interest litigation.
How You Can Support This Initiative
-
Please find the detailed letter below to understand the concerns and demands raised by the Awaken India Movement.
-
Every individual can contribute by sending an email to the concerned authorities using the list of email addresses provided below.
-
Your participation can help bring public attention to this important issue and encourage transparency, accountability, and protection of citizens’ rights.
To
presidentofindia@rb.nic.in, us.petitions@rb.nic.in, oo-asm@pmo.gov.in, min-hfm@gov.in, secyhfw@nic.in, dci@nic.in
aimindia1234@gmail.com, complaint.nhrc@nic.in, cr.nhrc@nic.in
URGENT LEGAL OBJECTION – Proposed First-in-Human Drug Trials in India | Article 21 & 72nd Parliamentary Report
Respected Sir/Madam,
I hereby register my STRONGEST OBJECTION to the proposal to permit multinational pharmaceutical companies to conduct FIRST-IN-HUMAN Phase I clinical trials of foreign-developed experimental drugs on Indian citizens. I call upon the Government of India to immediately halt this proposal in the interest of public safety, constitutional rights and human dignity.
On 12 November 2026, The Economic Times published a disturbing report titled “India may open doors to multinational pharma firms for first-in-human Phase I trials.” The report reveals that the Government has initiated discussions to allow foreign pharmaceutical companies to conduct first-in-human trials in India, potentially exposing Indian volunteers to experimental drugs whose effects in humans are not yet fully established.
INDIA MUST NOT BE TURNED INTO AN EXPERIMENTAL LABORATORY FOR GLOBAL PHARMACEUTICAL CORPORATIONS!
REMEMBER BILL GATES AND THE HPV VACCINE CONTROVERSY!
During 2009–2010, HPV vaccine studies involving approximately 23,000 young girls in Andhra Pradesh and Gujarat were conducted by PATH under a project funded by the Bill & Melinda Gates Foundation.
The 72nd Parliamentary Standing Committee Report, dated 30 August 2013, documented serious violations concerning informed consent, ethical safeguards and the protection of children.
The Parliamentary Committee specifically recommended legal action against PATH and raised serious concerns regarding violations of human rights.
AND WHAT DID BILL GATES SAY ABOUT INDIA?
In 2024, Bill Gates publicly described India as “a kind of laboratory to try things,” while discussing development programmes, triggering widespread public criticism.
These facts and Parliamentary findings demand the highest level of scrutiny before permitting any expansion of foreign-sponsored experimental drug trials in India.
SERIOUS CONSTITUTIONAL AND LEGAL OBJECTIONS
1. ARTICLE 21 – CONSTITUTION OF INDIA
The right to life, personal liberty, bodily integrity and human dignity cannot be compromised for commercial or experimental interests.
2. DRUGS AND COSMETICS ACT, 1940 & NEW DRUGS AND CLINICAL TRIALS RULES, 2019
Rules 6 and 19 provide for Ethics Committee registration and regulatory permission. Informed consent, safety oversight and compensation requirements must also be complied with.
Any clinical trial conducted in violation of these statutory requirements is unlawful and liable to regulatory and legal action.
3. THE 72ND PARLIAMENTARY STANDING COMMITTEE REPORT
The Government must account for the Committee’s findings concerning PATH and demonstrate that the serious violations identified will never be repeated.
MY FORMAL DEMANDS
I hereby demand:
Immediate suspension of the proposed regulatory expansion pending public consultation, parliamentary scrutiny and independent ethical review.
Complete disclosure of the proposed amendments, safeguards and their legal justification.
Strict protection of Indian citizens, particularly children and economically vulnerable persons, against exploitation in experimental drug research.
Public disclosure of action taken on the 72nd Parliamentary Committee’s recommendations concerning the Gates Foundation-funded HPV project.
A written, reasoned response from the concerned authorities addressing these objections.
FORMAL WARNING OF LEGAL ACTION
TAKE NOTICE that if the Government proceeds with any regulatory amendment that violates Article 21 of the Constitution or unlawfully dilutes mandatory protections for human participants, we reserve our right to challenge such action through appropriate legal proceedings, including Public Interest Litigation under Articles 32 and 226 of the Constitution of India.
We further reserve the right to seek intervention from the National Human Rights Commission, statutory regulatory authorities and competent courts, and to pursue all remedies available under Indian law.
This communication may be treated as a FORMAL REPRESENTATION AND LEGAL OBJECTION. Kindly acknowledge its receipt and communicate the Government’s response.
I urgently appeal to the Hon’ble President of India to take cognisance of this serious national concern and request that this representation be forwarded to the concerned authorities for examination and appropriate action before any such policy decision is taken.
INDIA IS NOT A LABORATORY! INDIAN CITIZENS ARE NOT GUINEA PIGS!
REFERENCES
1. Economic Times – 12 November 2026: Proposed First-in-Human Trials https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/india-may-open-doors-to-multinational-pharma-firms-for-first-in-human-phase-i-trials/amp_articleshow/135747898.cms
2. Times of India – Bill Gates’ “Laboratory to Try Things” Remark https://timesofindia.indiatimes.com/etimes/trending/bill-gates-faces-backlash-for-calling-india-a-laboratory-to-try-things-/amp_articleshow/115934216.cms
3. 72nd Parliamentary Standing Committee Report – HPV Vaccine Studies, 30 August 2013 https://thetruthpill.in/wp-content/uploads/2024/05/72nd-Report-of-the-Parliamentary-Standing-Committee-on-Health-regarding-irregularities-in-the-clinical-trial-of-the-HPV-vaccine-by-PATH-in-India-2013.pdf
Yours faithfully,
AWAKEN INDIA MOVEMENT (AIM) – NATIONAL EMAIL CAMPAIGN
Name: __________________________
City: __________________________
Also Read:

